01 December 2011
A clinical trial of glutathione supplementation in autism spectrum disorders
Janet K. KernABCDEFG, David A. GeierABCDEF, James B. AdamsADEG, Carolyn R. GarverAE, Tapan AudhyaABE, Mark R. GeierABCDEFGDOI: 10.12659/MSM.882125
Med Sci Monit 2011; 17(12): CR677-682
Abstract
Background: Recent evidence shows that subjects diagnosed with an autism spectrum disorder (ASD) have significantly lower levels of glutathione than typically developing children. The purpose of this study was to examine the use of two commonly used glutathione supplements in subjects diagnosed with an ASD to determine their efficacy in increasing blood glutathione levels in subjects diagnosed with an ASD.
Material/Methods: The study was an eight-week, open-label trial using oral lipoceutical glutathione (n=13) or transdermal glutathione (n=13) in children, 3–13 years of age, with a diagnosis of an ASD. Subjects underwent pre- and post-treatment lab testing to evaluate plasma reduced glutathione, oxidized glutathione, cysteine, taurine, free and total sulfate, and whole-blood glutathione levels.
Results: The oral treatment group showed significant increases in plasma reduced glutathione, but not whole-blood glutathione levels following supplementation. Both the oral and transdermal treatment groups showed significant increases in plasma sulfate, cysteine, and taurine following supplementation.
Conclusions: The results suggest that oral and transdermal glutathione supplementation may have some benefit in improving some of the transsulfuration metabolites. Future studies among subjects diagnosed with an ASD should further explore the pharmacokinetics of glutathione supplementation and evaluate the potential effects of glutathione supplementation upon clinical symptoms.
Keywords: Glutathione - therapeutic use, Dietary Supplements, Child, Preschool, Child Development Disorders, Pervasive - drug therapy, Child, Adolescent, Metabolic Networks and Pathways, Sulfur - metabolism
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
Database Analysis
Maternal Exposure to Environmental Air Pollution and Premature Rupture of Membranes: Evidence from Southern...Med Sci Monit In Press; DOI: 10.12659/MSM.943601
Animal Research
Enhanced Bone Healing Through Systemic Capsaicin Administration: An Experimental Study on Wistar RatsMed Sci Monit In Press; DOI: 10.12659/MSM.942485
Clinical Research
Differential Inflammatory Responses in Adult and Pediatric COVID-19 Patients: Implications for Long-Term Co...Med Sci Monit In Press; DOI: 10.12659/MSM.944052
Clinical Research
Effectiveness of Shoulder Taping in Treating Hemiplegic Shoulder Subluxation: A Randomized Controlled Study...Med Sci Monit In Press; DOI: 10.12659/MSM.944222
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952